Filling the COVID Vaccine Gaps
**DIY COVID-19 Vaccines: A Tale of Innovation and Ingenuity**
In the midst of the COVID-19 pandemic, individuals have turned to innovative solutions to address challenges, particularly in accessing vaccines. This article delves into two fascinating stories of individuals leveraging their skills to create their own vaccination solutions, highlighting both the potential and implications of such endeavors.
**John Wensworth: Crafting a DIY COVID-19 Vaccine**
John Wensworth, a bioengineer with minimal wet lab experience from his undergraduate days, embarked on an intriguing project—creating his own COVID-19 vaccine. His journey began with researching the feasibility of homemade vaccines and discovered that it could be done without specialized equipment or licensing, provided it wasn't distributed to others.
The most significant cost in John's venture was $850 for custom synthesized peptides, which are short protein segments from the COVID virus. These peptides, each under 25 amino acids, pose no danger as they cannot function as proteins. John sourced these online, realizing that companies offer affordable synthesis services. He opted to purchase double the required amount at minimal extra cost, anticipating potential mistakes.
The process involved dissolving each component separately and freezing them until needed. A crucial step was circularizing the peptides by adding activated charcoal and shaking the mixture for three hours. Finally, he mixed everything, pipetted it into doses, and administered it via nasal application, believing it to be safer and more effective since the virus enters through the nose.
Despite his success, John chose not to publish his recipe, prompting calls for further exploration of this approach. His project underscores the potential for DIY vaccines, especially mRNA-based ones, which are inherently safe.
**Hugh Ma: Turbo Vaxx - Simplifying Vaccine Appointment Booking**
While John focused on creating a vaccine, Hugh Ma addressed another challenge: navigating the complex vaccine appointment system. Frustrated by the difficulty in securing an appointment for his mother in New York City, Hugh developed "Turbo Vaxx," a website that streamlined the process.
In just two weeks and for $50, Hugh created Turbo Vaxx, which scoured multiple sites to find available appointments. His initiative not only helped his family but also gained traction, aiding others in overcoming the same obstacles. This story mirrors a broader trend where individuals use tech skills to innovate during crises.
**Implications of DIY Vaccines**
The stories of John and Hugh highlight the potential of citizen science and innovation during public health crises. DIY mRNA vaccines, unlike traditional ones, pose minimal risk due to their harmless nature. However, challenges remain, such as verifying efficacy and addressing regulatory hurdles.
John's nasal vaccine approach is particularly noteworthy for its method of delivery, potentially offering better immune responses where the virus enters. Yet, it raises questions about testing methods, which currently focus on blood tests, possibly missing nasally administered vaccines' effects.
**Conclusion**
These tales of innovation during COVID-19 offer a glimpse into the future of citizen science and healthcare. While DIY vaccines like John's are experimental, they challenge conventional approaches and inspire further exploration. Meanwhile, projects like Turbo Vaxx exemplify how technology can be harnessed to address systemic issues in vaccine distribution.
As we navigate future health crises, such stories remind us that innovation thrives when individuals are empowered to tackle challenges creatively, fostering a culture where science and technology work hand-in-hand for the greater good.